Brain Biosciences, Inc. (USA)
Brain Biosciences, Inc. is a Rockville, Maryland-based medical imaging company whose LONGMILE Veterinary Imaging division develops MILE-PET® PET scanners for standing, sedated horses.
Last updated September 28, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Brain Biosciences, Inc. is a United States-based medical imaging company headquartered in Rockville, Maryland. Its principal commercial-facing activity in veterinary medicine is carried out through LONGMILE Veterinary Imaging, a division that markets and develops positron emission tomography (PET) technology for animal patients. The company's stated mission is to bring the full power of PET — a molecular imaging technique long established in human medicine — to equine veterinarians by designing imaging devices that meet the specific needs of that community. The flagship offering is MILE-PET®, described by the company as the only PET device for imaging the limbs of standing, lightly sedated horses without anesthesia. This is a meaningful technical distinction: conventional PET systems generally require general anesthesia and a horizontal patient, which is impractical for horses. By enabling molecular imaging in a standing, sedated equine patient, LONGMILE aims to make PET practical in equine clinical and research settings. The company positions itself around scientific rigor as much as hardware. It maintains a volunteer Science Advisory Board composed of prominent equine and veterinary imaging specialists from institutions such as the University of California, Davis; Rood and Riddle Equine Hospital; the Southern California Equine Foundation; Virginia Tech's Marion DuPont Scott Equine Medical Center; and the University of Montreal. The company states that since 2015 it has worked with top researchers to establish the science behind equine PET, and it publishes research in support of that effort. Leadership listed publicly includes David Beylin as Executive Director, Pavel Stepanov as Director of Product Development, Val Zavarzin as Director of R&D, Ruslan Melnikov as Production Manager, Sergey Anishchenko as Director of the MotionTracking Program, Ilia Shkolnik as Director of Software Integration, Ying Li as Vice President of Finance, and advisor Irving Weinberg, MD, PhD. The company is privately held and does not appear to be publicly listed. Its commercial identity is therefore best understood as a specialized veterinary molecular imaging business operating under the Brain Biosciences corporate umbrella, with the LONGMILE brand serving as its market-facing name in the equine veterinary community.
History
Brain Biosciences, Inc. is a United States company based in Rockville, Maryland. Public information about the corporate entity itself is limited; its most visible commercial activity is conducted through LONGMILE Veterinary Imaging, described on its website as a division of Brain Biosciences, Inc. The LONGMILE effort is focused on translating positron emission tomography (PET), a powerful clinical modality in human medicine, into veterinary practice. The company notes that PET has historically been underused in veterinary medicine and frames its mission as creating a solid scientific foundation for PET applications in the diagnosis and treatment of disease in large and small animals, with an initial emphasis on equine patients. A central technical challenge in equine PET is patient positioning and anesthesia. Conventional PET scanners require the patient to be anesthetized and positioned horizontally, which is difficult and risky for horses. LONGMILE's answer is MILE-PET®, which the company describes as the only PET device for imaging the limbs of standing, lightly sedated horses without anesthesia. This allows molecular imaging to be performed in a standing sedated equine patient, a capability the company presents as a first for the field. The company states that since 2015 it has worked with top researchers to establish the science behind equine PET, and it maintains a publications page reflecting that research orientation. To guide research priorities, LONGMILE assembled a volunteer Science Advisory Board of prominent veterinarians and imaging specialists. Listed members include Rick Arthur (Equine Medical Director, School of Veterinary Medicine, University of California, Davis), Larry Bramlage (Partner, Rood and Riddle Equine Hospital), Joe Dowd (President, Southern California Equine Foundation), Michael Erskine (Director, Virginia Tech's Marion DuPont Scott Equine Medical Center), Larry D. Galuppo (Professor & Chief, Equine Surgery, UC Davis), Sheila Laverty (Director, Comparative Orthopaedic Research Lab, University of Montreal), Claudia Sonder (President, Napa Community Animal Response Team; Emeriti Director of Equine Outreach, UC Davis), Mathieu Spriet (Chairman; Associate Professor of Diagnostic Imaging, UC Davis), and Susan Stover (Professor of Anatomy, Physiology & Cell Biology, UC Davis). The company's public team listing includes David Beylin as Executive Director, Pavel Stepanov as Director of Product Development, Val Zavarzin as Director of R&D, Ruslan Melnikov as Production Manager, Sergey Anishchenko as Director of the MotionTracking Program, Ilia Shkolnik as Director of Software Integration, Ying Li as Vice President of Finance, and Irving Weinberg, MD, PhD, as an advisor. The company is privately held. Its history is therefore one of a small, research-driven medical device developer building a specialized equine imaging niche under the Brain Biosciences corporate name and the LONGMILE market brand.
- 2015
Company states it began working with top researchers to establish the science behind equine PET.
LONGMILE Veterinary Imaging, a division of Brain Biosciences, Inc., markets MILE-PET®, described as the only PET device for imaging limbs of standing, lightly sedated horses without anesthesia.
Company assembles a volunteer Science Advisory Board of prominent equine and veterinary imaging specialists to guide research priorities.
Products and positioning
Specialized veterinary molecular imaging provider bringing human-grade PET technology to equine medicine, with a research-first, science-advisory-backed approach.
MILE-PET®
PET imaging device for imaging limbs of standing, lightly sedated horses without anesthesia.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/brain-biosciences-inc-usa · Editorial policy · How profiles are compiled